-葡萄糖共载体2和葡萄糖水平影响清细胞细胞癌的进展
Yujiro Nagata1, Ikko Tomisaki1, Hisami Aono1
1Department of Urology, School of Medicine, University of Occupational and Environmental Health, Kitakyushu 807-8555, Japan.
International journal of molecular sciences
|June 26, 2025
概括
-葡萄糖共运输体2 (SGLT2) 的抑制显著降低了清细胞细胞癌 (ccRCC) 的进展和增强了亡. SGLT2 抑制剂可能为ccRCC患者,特别是糖尿病患者提供新的治疗潜力.
科学领域:
- 在瘤学瘤学.
- 腎臟病學 (nephrology) 是一種醫學.
- 内分泌学 在内分泌学.
背景情况:
- 在清细胞细胞癌 (ccRCC) 进展中,-葡萄糖共运输体2 (SGLT2) 的作用尚不清楚.
- 了解SGLT2的生物学意义对于确定ccRCC中的新治疗点至关重要.
研究的目的:
- 研究SGLT2在ccRCC瘤进展中的作用.
- 评估SGLT2抑制对ccRCC细胞增殖,迁移和亡的疗效.
主要方法:
- 使用KMRC-1 ccRCC细胞系与VHL基因突变.
- 评估了SGLT2抑制剂达帕格利弗洛辛和SGLT2抑制剂在不同葡萄糖度下对ccRCC细胞的影响.
- 测量了细胞活力,迁移,殖民地形成和亡.
主要成果:
- 达帕格利弗洛辛显著降低了ccRCC细胞的增殖和迁移,特别是在高葡萄糖条件 (25mM) 中.
- 此外,SGLT2的淘汰也降低了细胞活力,迁移和殖民地形成.
- 抑制SGLT2在正常血糖 (5毫米) 和严重高血糖 (25毫米) 模型中都表现出有效性,增强了亡.
结论:
- 在具有VHL突变的ccRCC的进展中,SGLT2发挥着重要作用.
- SGLT2 抑制剂显示出作为ccRCC的新型治疗策略的希望,特别是在同时患有糖尿病的患者中.
相关概念视频
Secondary Active Transport
125.8K
One example of how cells use the energy contained in electrochemical gradients is demonstrated by glucose transport into cells. The ion vital to this process is sodium (Na+), which is typically present in higher concentrations extracellularly than in the cytosol. Such a concentration difference is due, in part, to the action of an enzyme “pump” embedded in the cellular membrane that actively expels Na+ from a cell. Importantly, as this pump contributes to the high concentration of...
125.8K
Glucose Transporters
24.3K
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
24.3K
Glucose Absorption Into the Small Intestine
32.5K
Complex carbohydrates consumed cannot be absorbed into the small intestine in their original form. First, they must be hydrolyzed to a monosaccharide form such as glucose or galactose. These monosaccharides are then transported across the intestinal membrane and into the blood via transcellular transport. The intestinal epithelial cells allow the movement of these monosaccharides with a defined 'entry' through membrane transporter proteins present on their apical membrane and...
32.5K
Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
Transcellular Transport of Solutes
3.9K
Transcellular transport of solutes is the movement of substances like monosaccharides and amino acids through polarized cells. This transport mechanism is primarily seen in epithelial and endothelial cells aided by membrane transport proteins such as channels and transporters. The tight junctions between these cells confine the membrane proteins to the two sides of the cell. The epithelial cells have distinct apical and basolateral domains. In contrast, the endothelial cells show the luminal...
3.9K
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K


